STRYKER CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 335.6 USD | -0.46% |
|
+3.13% | +12.07% |
| 04-15 | Truist Securities Adjusts Stryker Price Target to $364 From $345 | MT |
| 04-15 | BTIG Adjusts Stryker's Price Target to $366 From $353 | MT |
Chart calendar Stryker Corporation
dc37069b4.SDiYfme39Hu6u5VnKyFwyqhSfD_LtCVNk7NGs6Mvr_Y.BXrxTTHBvxH-zcZKSXg1q-43UQ6q11wH-Ml3nuJX488EUcJMVIOZT-3M0A~7150e1f25f34cf6b84098a0e204e5fd2
Upcoming events on Stryker Corporation
Past events on Stryker Corporation
| 26/03/2024 | Ex-dividend day |
| 16/03/2024 | Roth Conference |
| 29/02/2024 18:45 | Citi Unplugged Medtech and Life Sciences Access Day |
| 31/01/2024 | American College of Foot and Ankle Surgeons Meeting |
| 30/01/2024 21:30 | Q4 2023 Earnings Call |
| 30/01/2024 21:05 | Q4 2023 Earnings Release |
| 27/12/2023 | Ex-dividend day |
| 29/11/2023 18:20 | Evercore ISI HealthCONx Conference |
| 08/11/2023 19:30 | Investor Day |
| 02/11/2023 20:30 | Q3 2023 Earnings Call |
| 02/11/2023 20:05 | Q3 2023 Earnings Release |
| 17/10/2023 | North American Spine Society Meeting |
| 27/09/2023 | Ex-dividend day |
| 07/09/2023 18:30 | Wells Fargo Healthcare Conference |
| 03/08/2023 21:30 | Q2 2023 Earnings Call |
| 03/08/2023 21:05 | Q2 2023 Earnings Release |
| 28/06/2023 | Ex-dividend day |
| 10/05/2023 14:00 | Annual General Meeting |
| 01/05/2023 21:30 | Q1 2023 Earnings Call |
| 01/05/2023 21:05 | Q1 2023 Earnings Release |
Past dividends on Stryker Corporation
| 26/03/2024 | Quarterly 0.8 USD |
| 27/12/2023 | Quarterly 0.8 USD |
| 27/09/2023 | Quarterly 0.75 USD |
| 28/06/2023 | Quarterly 0.75 USD |
| 29/03/2023 | Quarterly 0.75 USD |
| 28/12/2022 | Quarterly 0.75 USD |
| 28/09/2022 | Quarterly 0.695 USD |
| 28/06/2022 | Quarterly 0.695 USD |
| 29/03/2022 | Quarterly 0.695 USD |
| 29/12/2021 | Quarterly 0.695 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 14 884 14 855 0.2% | 14 351 14 413 -0.43% | 17 108 17 053 0.32% | 18 449 18 207 1.33% | 20 498 20 280 1.08% | 22 174 |
|
EBITDA Million USD | Released Forecast Spread | 4 222 4 248 -0.61% | 3 839 3 818 0.55% | 4 753 4 856 -2.12% | 4 755 4 724 0.65% | 5 348 5 321 0.51% | 5 972 |
|
EBIT Million USD | Released Forecast Spread | 3 908 3 904 0.11% | 3 499 3 479 0.56% | 4 382 4 409 -0.61% | 4 384 4 337 1.07% | 4 955 4 900 1.13% | 5 574 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 562 2 629 -2.55% | 1 954 2 444 -20.04% | 2 281 2 810 -18.81% | 2 683 3 133 -14.36% | 3 673 3 703 -0.8% | 4 561 |
|
Net income Million USD | Released Forecast Spread | 2 083 2 209 -5.71% | 1 599 1 901 -15.89% | 1 994 2 146 -7.1% | 2 358 2 595 -9.14% | 3 165 3 056 3.58% | 3 877 |
|
EPS USD | Released Forecast Spread | 5,48 5,75 -4.66% | 4,20 5,08 -17.25% | 5,21 5,78 -9.91% | 6,17 6,99 -11.73% | 8,25 8,14 1.29% | 10,0 |
| Announcement Date | 28/01/20 | 27/01/21 | 27/01/22 | 31/01/23 | 30/01/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4 701 4 647 1.15% | 4 275 4 191 2% | 4 493 4 535 -0.93% | 4 479 4 463 0.35% | 5 202 4 967 4.74% | 4 778 4 560 4.78% | 4 996 4 830 3.44% | 4 909 4 864 0.93% | 5 815 5 603 3.78% | 5 105 | 5 392 | 5 345 | 6 333 | 5 484 |
|
EBITDA Million USD | Released Forecast Spread | 1 378 1 431 -3.72% | 1 026 1 027 -0.14% | 1 156 1 194 -3.18% | 1 092 1 170 -6.64% | 1 481 1 453 1.91% | 1 102 1 057 4.27% | 1 314 1 224 7.32% | 1 247 1 254 -0.6% | 1 685 1 633 3.19% | 1 223 | 1 453 | 1 430 | 1 902 | 1 383 |
|
EBIT Million USD | Released Forecast Spread | 1 285 1 314 -2.23% | 934 930 0.47% | 1 063 1 105 -3.76% | 1 001 1 069 -6.4% | 1 386 1 339 3.47% | 1 006 963 4.5% | 1 216 1 131 7.52% | 1 149 1 164 -1.31% | 1 584 1 530 3.51% | 1 121 | 1 345 | 1 322 | 1 799 | 1 281 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 757 1 092 -30.68% | 386 708 -45.48% | 720 815 -11.62% | 816 777 5.06% | 761 1 070 -28.9% | 679 762 -10.89% | 899 908 -0.95% | 869 940 -7.55% | 1 226 1 298 -5.52% | 893 | 1 108 | 1 074 | 1 626 | 1 034 |
|
Net income Million USD | Released Forecast Spread | 662 836 -20.81% | 323 635 -49.1% | 656 714 -8.17% | 816 694 17.51% | 563 920 -38.78% | 592 659 -10.13% | 738 770 -4.13% | 692 793 -12.77% | 1 143 1 104 3.49% | 761 | 943 | 936 | 1 352 | 943 |
|
EPS USD | Released Forecast Spread | 1,73 2,44 -28.95% | 0,84 1,65 -48.99% | 1,72 1,90 -9.35% | 2,14 1,77 20.9% | 1,47 2,45 -40.1% | 1,54 1,65 -6.59% | 1,93 1,99 -2.9% | 1,80 2,04 -11.68% | 2,98 2,92 2.08% | 1,93 | 2,42 | 2,39 | 3,46 | 2,45 |
| Announcement Date | 27/01/22 | 28/04/22 | 26/07/22 | 31/10/22 | 31/01/23 | 01/05/23 | 03/08/23 | 02/11/23 | 30/01/24 | - | - | - | - | - |
| 28/04/2024 | YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD.: Q1 2024 Earnings Release |
| 28/04/2024 | BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | DOUBLE MEDICAL TECHNOLOGY INC.: Q1 2024 Earnings Release |
| 30/04/2024 21:05 | STRYKER CORPORATION: Q1 2024 Earnings Release |
| 30/04/2024 | JAPAN LIFELINE CO., LTD.: Q4 2023 Earnings Release |
| 01/05/2024 07:00 | SMITH & NEPHEW PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 01/05/2024 21:05 | GLAUKOS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | AXONICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 11:00 | ENOVIS CORPORATION: Q1 2024 Earnings Release |
| 05/05/2024 | ORTHOPEDIATRICS CORP.: Q1 2024 Earnings Release |
Past sector events for Stryker Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SYK Stock
- Calendar Stryker Corporation
